Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology.

@article{Goodwin2009EvidencebasedGF,
  title={Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology.},
  author={G M Goodwin},
  journal={Journal of psychopharmacology},
  year={2009},
  volume={23 4},
  pages={
          346-88
        }
}
  • G. Goodwin
  • Published 1 June 2009
  • Psychology, Medicine
  • Journal of psychopharmacology
The British Association for Psychopharmacology guidelines specify the scope and target of treatment for bipolar disorder. The second version, like the first, is based explicitly on the available evidence and presented, like previous Clinical Practice guidelines, as recommendations to aid clinical decision making for practitioners: they may also serve as a source of information for patients and carers. The recommendations are presented together with a more detailed but selective qualitative… 

Figures from this paper

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder, and recommend strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment.

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

The guidelines primarily cover the pharmacological management of withdrawal, short- and long-term substitution, maintenance of abstinence and prevention of complications, where appropriate, for substance abuse or harmful use or addiction as well management in pregnancy, comorbidity with psychiatric disorders and in younger and older people.

The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines

The most important and still unmet need is to merge all the guidelines that concern different phases of the illness into a single one and in this way consider BD as a single unified disorder, which is the real world fact.

Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial Design

  • M. Tohen
  • Medicine
    The international journal of neuropsychopharmacology
  • 2017
The rationale and the method with which all data and opinions are combined in order to produce an evidence-based operationalized but also user-friendly guideline and a specific algorithm are described in detail in this paper.

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders

These British Association for Psychopharmacology guidelines are designed to address this problem by providing an accessible up-to-date and evidence-based outline of the major issues, especially those relating to reliable diagnosis and appropriate treatment.

circadian rhythm disorders British Association for Psychopharmacology consensus statement on evidence-based treatment of

These British Association for Psychopharmacology guidelines are designed to address this problem by providing an accessible up-to-date and evidence-based outline of the major issues, especially those relating to reliable diagnosis and appropriate treatment.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

The Mood Disorder CPG is the first Clinical Practice Guideline to address both depressive and bipolar disorders and provides up-to-date recommendations and guidance within an evidence-based framework, supplemented by expert clinical consensus.

Beyond the Guidelines for Bipolar Disorder: Practical Issues in Long-Term Treatment with Lithium

  • C. CalkinM. Alda
  • Medicine, Psychology
    Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 2012
Focus was on specific practical issues of lithium treatment, including the selection and initiation of long-term treatment, and management and discontinuation (if indicated) of lithium prophylaxis.
...

References

SHOWING 1-10 OF 268 REFERENCES

Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for Psychopharmacology

  • G. Goodwin
  • Medicine, Psychology
    Journal of psychopharmacology
  • 2003
The guidelines cover the diagnosis of bipolar disorder, clinical management and strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment.

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

These guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing and management, next-step treatment, relapse prevention, treatment of relapse, and stopping treatment.

The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.

These guidelines provide clear pathways for addressing common clinical questions in a manner that can be used to inform clinicians and educate patients regarding the relative merits of a variety of interventions.

Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials.

A large-scale study, the Bipolar Affective Disorder: Lithium Anticonvulsant Evaluation (BALANCE) trial, is proposed to compare the effectiveness of lithium, valproate and the combination of lithium andValproate.

Antidepressants in bipolar disorder: the case for caution.

There is a strong rationale for a cautious approach to antidepressant use in bipolar disorder, consistent with, and perhaps even more strongly than, the APA guidelines, according to an interpretation of the evidence.

Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial.

This intervention consists of improving patients' self-management skills through psychoeducation; supporting providers' decision making through simplified practice guidelines; and enhancing access to care, continuity of care, and information flow through the use of a nurse care coordinator.

Randomized trial of a population-based care program for people with bipolar disorder

A systematic care program for bipolar disorder significantly reduces risk of mania over 12 months, and preliminary results suggest a growing effect on depression over time, but longer follow-up will be needed.

The Expert Consensus Guidelines for treating depression in bipolar disorder.

The experts' antidepressant dose and dosing schedule recommendations are equivalent for unipolar and bipolar depression, but the experts recommend a faster discontinuation of antidepressants during the maintenance phase in bipolar patients to reduce the risk of rapid cycling.

Use of antipsychotic drugs and lithium in mania

  • J. Cookson
  • Psychology, Medicine
    British Journal of Psychiatry
  • 2001
The efficacy and mode of action of antipsychotic drugs in mania is reviewed, and the differences between official guidelines and routine clinical practice in the use of these agents for mania are considered.

Valproate for acute mood episodes in bipolar disorder.

There is consistent, if limited, evidence to suggest that valproate is an efficacious treatment for acute mania, andValproate may be less effective than olanzapine but may cause less sedation and weight gain.
...